SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $14,000 | -33.3% | 58,386 | 0.0% | 0.00% | – |
| Q4 2015 | $21,000 | -79.4% | 58,386 | 0.0% | 0.00% | – |
| Q3 2015 | $102,000 | -21.5% | 58,386 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $130,000 | +39.8% | 58,386 | +21.6% | 0.00% | – |
| Q1 2015 | $93,000 | -30.1% | 48,005 | -4.7% | 0.00% | -100.0% |
| Q4 2014 | $133,000 | -10.7% | 50,368 | +1.5% | 0.00% | 0.0% |
| Q3 2014 | $149,000 | -17.7% | 49,620 | +12.3% | 0.00% | 0.0% |
| Q2 2014 | $181,000 | +9.7% | 44,193 | +15.1% | 0.00% | 0.0% |
| Q1 2014 | $165,000 | -17.9% | 38,383 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $201,000 | -1.0% | 38,383 | +19.3% | 0.00% | 0.0% |
| Q3 2013 | $203,000 | +32.7% | 32,182 | +4.8% | 0.00% | 0.0% |
| Q2 2013 | $153,000 | – | 30,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |